Software Healthcare Sector

Oragenics

Market Cap: US$2.3m

A development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States.

Virax Biolabs Group

Market Cap: US$2.3m

A biotechnology company, focuses on immune response detection, T cell immune profiling, and the development of in vitro diagnostic technologies for viral and immune-mediated diseases in the United Kingdom, the United States, and China.

SOHM

Market Cap: US$2.3m

Develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States.

Biotricity

Market Cap: US$2.3m

A medical technology company, provides biometric data monitoring solutions in the United States.

VitaSpring Biomedical

Market Cap: US$2.3m

A development-stage biomedical company, engages in the research, development, and commercialization of wellness and healthy lifestyle products.

Delivra Health Brands

Market Cap: CA$3.1m

Through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide.

City View Green Holdings

Market Cap: CA$3.1m

A consumer-packaged goods company, formulates, produces, and sells cannabis edibles and related products in Canada.

BioVaxys Technology

Market Cap: CA$3.1m

A clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms and immuno-diagnostics.

Imaging Biometrics

Market Cap: UK£1.6m

Provides clinical treatments to patients in the field of medical imaging diagnostics in the United Kingdom, China, the European Union, South America, Australia, and the United States.

GlucoTrack

Market Cap: US$2.1m

A medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States.

Zero Candida Technologies

Market Cap: CA$2.9m

A technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis.

OMID Holdings

Market Cap: US$2.1m

A health and wellness company, engages in the manufacture and sale of CBD-based products.

AI Energy

Market Cap: US$2.1m

A development stage company, focuses on discovery and development of analgesic and anti-inflammatory products based on the proprietary MPL-TL (tripeptofen) compound.

nDatalyze

Market Cap: CA$2.9m

Provides technologically based solutions related to applying machine learning to a records database to predict probable mental health conditions.

Uscom

Market Cap: AU$3.1m

Designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe.

Procyon

Market Cap: US$2.0m

Manufactures and markets wound and skin care products primarily in the United States.

Anatara Lifesciences

Market Cap: AU$2.8m

Engages in the research, development, and commercialization of evidence-based solutions for gastrointestinal diseases in Australia.

Nu-Med Plus

Market Cap: US$2.0m

A medical device company, engages in the design, innovation, development, enhancement, and commercialization of medical devices worldwide.

Silexion Therapeutics

Market Cap: US$2.0m

A biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors.

Yubo International Biotech

Market Cap: US$2.0m

Through its subsidiaries, focuses on the research, development, and application of endometrial stem cells.

Breakthrough Chemistry

Market Cap: US$2.0m

Develops compounds and formulations that defy the norms prevalent in chemical industries.

Shuttle Pharmaceuticals Holdings

Market Cap: US$2.0m

A clinical stage pharmaceutical company, develops novel therapies to treat cancers.

Nexalis Therapeutics

Market Cap: AU$2.8m

A biotechnology company, develops and sells registrable inhaled drug-device combinations in Australia.

Oncology Pharma

Market Cap: US$2.0m

An oncology company, develops, manufactures, and commercializes therapeutics.

Decoy Therapeutics

Market Cap: US$2.0m

Operates as a pre-clinical stage biotechnology company.

Mobile-health Network Solutions

Market Cap: US$1.9m

An investment holding company, provides telehealth solutions primarily in Singapore.

Cynata Therapeutics

Market Cap: AU$2.7m

Engages in the development and commercialization of proprietary induced pluripotent stem cell and mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia.

INVO Fertility

Market Cap: US$1.9m

A healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients.

Kanabo Group

Market Cap: UK£1.4m

A digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices.

Mettitech Group Holdings

Market Cap: US$1.9m

A media company, engages in Web, mobile applications, and film production and distribution activities.

Vycor Medical

Market Cap: US$1.8m

Designs, develops, and markets neurological medical devices and therapies in the United States and Europe.

Neural Therapeutics

Market Cap: CA$2.5m

An ethnobotanical drug discovery and development company, develops over-the-counter dietary supplements and psychedelic-based therapeutic drugs to treat mental illnesses in Canada.

DXS International

Market Cap: UK£1.3m

A healthcare IT company, develops and distributes clinical decision support solutions to general practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa.

Osteopore

Market Cap: AU$2.5m

A regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Taiwan, Indonesia, the Netherlands, the United Arab Emirates, Australia, and internationally.

Hellenic Dynamics

Market Cap: UK£1.3m

Engages in the cultivation and supply of tetrahydrocannabinol (THC) dominant strains of medical cannabis flowers in Europe.

InVitro International

Market Cap: US$1.8m

Develops test kits for non-animal testing applications in the United States and internationally.